Navigation Links
Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
Date:4/20/2009

NORWOOD, Mass. April 20 /PRNewswire/ -- Advanced Instruments, Inc. today introduced the Advanced(R) 2020-BIO Multi-Sample Osmometer as the first true automation-friendly osmometer for the biopharmaceutical industry.

"The Advanced(R) 2020-BIO Multi-Sample Osmometer is specifically designed for -- and completely redefines -- automation capabilities for osmolality testing in the biopharmaceutical laboratory," said Kelly Peterson, Product Manager, Advanced Instruments (www.aicompanies.com). "The 2020-BIO system development is in response to emerging demand in the pharmaceutical industry to integrate osmolality testing within an automated platform environment."

"Based on an extension of the industry-proven Advanced 2020 Osmometer, the 2020-BIO includes a host of features which enable fast and simple integration of the system with liquid handling robotics and laboratory automation platforms," Peterson said.

The 2020-BIO has been successfully applied to automate osmolality testing in applications ranging from cell culture process development and optimization to biopharmaceutical manufacturing and process control - It can also be extended to pharmaceutical research and drug development applications including formulation development, product stability testing, and drug safety and metabolism testing.

Major features of the new 2020-BIO include:

  • Freezing point technology -- The industry-preferred method for determining sample concentration
  • Automation friendly system design allows easy access for liquid handling
    '/>"/>

SOURCE Advanced Instruments, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
(Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/19/2014)... Tigard, OR and Hershey, PA (PRWEB) December 19, ... (OTC Pink: BJCT), a leading developer and manufacturer ... has entered into an agreement with Immunomic Therapeutics, ... Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ ... receives an option for an exclusive Worldwide license ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... Oct. 1 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... preclinical results for its CYT387 JAK1/JAK2 inhibitor program ... and selectivity profile which may provide significant clinical ... Phase I/II clinical study at Mayo Clinic in ...
... CITY, Oct. 1 /PRNewswire-FirstCall/ - Medicago U.S.A. Inc., ... MDG), a biotechnology company focused on developing highly ... technologies and Virus-Like Particles (VLPs), today announced that ... (D-NC) and U.S. Congressman David Price (D-NC), are ...
... (OTC Bulletin Board: BHRT ) a company ... cell therapies for the treatment of cardiovascular diseases, announced ... Seaside National Bank and Trust for a $980,000 loan ... with Bank of America. The loan is subject to ...
Cached Biology Technology:YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference 2YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference 3Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility 2Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility 3Bioheart, Inc. Announces Loan to be Assumed by Seaside 2Bioheart, Inc. Announces Loan to be Assumed by Seaside 3
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... pleasantly salty without adding more salt? Change the bread,s texture ... ACS, Journal of Agricultural and Food Chemistry that ... perceive bread as having saltier taste. The process could become ... risk factor for high blood pressure and heart disease. ...
... Every day, the human body produces new cells to regenerate ... this happens, the cells make copies of their DNA that ... process of copying the DNA, also called replication, is very ... DNA that are associated with malignant transformation or ageing. ...
... , Nov. 19, 2013 Dynasil Corporation of ... its contract research subsidiary, RMD Inc., has received four grants ... Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) ... continues to be on the cutting edge of new technologies," ...
Cached Biology News:Spanish scientists identify a new ancestral enzyme that facilitates DNA repair 2Dynasil's RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy 2Dynasil's RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy 3
Human RUNX2/CBFA1 MAb (Clone 232902)...
Lipid-rich bovine serum albumin for cell culture (1). It is chromatographically purified and has an IgG content 0.1% (w/w)....
normal rat IgM AF647...
GlutaMAX-I Supplement...
Biology Products: